BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
a 48-week, 2-arm parallel group, "fixed combination" beclomethasone dipropionate plus
formoterol fumarate versus formoterol in patients with severe chronic obstructive pulmonary
disease